04 May 2020

Germany amends Foreign Trade Act – On the road to protectionism?

TRADE ASSOCIATIONS CRITICISE THE NEW LAW FOR GOING TOO FAR

In the light of the corona crisis, the German government fears a “sell-out” of German companies and the loss of important know-how to countries like China. In the midst of the crisis, the Federal Cabinet passed the amendment to the Foreign Trade and Payments Act (AWG) at the beginning of April. It is envisaged that in future, investments by foreigners in German companies will be subject to much stricter governmental control and will be easier to prohibit. The leading economic associations in Germany see the planned changes as a hinderance to the transaction market and have launched an initiative of associations against the amendment of the law. In our GSK Update, we have summarized the most important amendments to the Foreign Trade and Payments Act and explain which companies will be particularly affected by the changes.

Print


Press contact
Christine Ström
+49 30 203907-7763
presse@gsk.de

Back

GSK Updates
  • 24 August 2021

    GSK Update: New marketing rules for investment management companies

    Read more
  • 23 June 2021

    GSK Update: The new German law on corporate due diligence in supply chains

    Read more
  • 21 June 2021

    GSK Update: Global data transfer: The new standard data protection clauses – What needs to be done?

    Read more
Contact person

Dr. Andreas Bauer, LL.M.

Partner*

+49 89 288174-74

andreas.bauer@gsk.de

* Partner: A partner within the meaning of the partnership company law.
   Local Partner: not a partner within the meaning of the partnership company law.
CO2 Neutral